New gout drug trial seeks to tame painful flares
NCT ID NCT07280156
Summary
This study is testing whether a new medication called PRX-115, given through an IV drip, can help control gout in people who haven't responded well to standard pills. About 150 adults with gout will receive either the actual drug or a placebo (inactive solution) over 24 weeks, with some also taking a common immune-modulating drug called methotrexate. The main goal is to see if PRX-115 can safely and effectively lower uric acid levels in the blood, which is key to preventing painful gout attacks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bioclinical Research Alliance, Inc
RECRUITINGMiami, Florida, 33155, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.